BioCardia BCDA
NASDAQ BCDA
$1.10 -0.01 (-0.90%)
At close: Sep 9, 2026 · 4:00 PM EDT

BioCardia (BCDA) Income from Discontinued Operations (2010 - 2012)

BioCardia's (BCDA) quarterly Income from Discontinued Operations came in at $104000.0 in Q4 2012, up 2500.0% year-over-year from $4000.0 in Q1 2012, and down 80.45% quarter-over-quarter from $532000.0 in Q3 2012.

Analysis

BioCardia (BCDA) Income from Discontinued Operations (2010 - 2012) Analysis & Trends

BioCardia (BCDA) has reported Income from Discontinued Operations for 3 consecutive years, with $104000.0 the latest figure, recorded in Q4 2012.

  • On a quarterly basis, Income from Discontinued Operations rose 2500.0% year-over-year to $104000.0 in Q4 2012; TTM through Dec 2012 was $636000.0, a 94.54% decrease from a year earlier, with the FY2012 full-year figure at $636000.0, down 94.63% from the prior year.
  • Income from Discontinued Operations was $104000.0 for Q4 2012 at BioCardia, down from $532000.0 in the prior quarter.
  • Over five years, Income from Discontinued Operations peaked at $12.3 million in Q2 2011 and troughed at -$8.0 million in Q3 2010.
  • A 3-year average of $494625.0 and a median of -$96000.0 in 2011 frame the typical range for Income from Discontinued Operations.
  • Across the five-year window, Income from Discontinued Operations soared 94.95% in 2011 and surged 2500.0% in 2012, its largest moves.
  • Over 3 years, Income from Discontinued Operations stood at -$330000.0 in 2010, then jumped by 101.21% to $4000.0 in 2011, then surged by 2500.0% to $104000.0 in 2012.
  • The last three Income from Discontinued Operations figures came in at $104000.0 (Q4 2012), $532000.0 (Q3 2012), and $4000.0 (Q4 2011), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Krystal Biotech 10.60 Bn 9.76 Bn 112.79 Mn -
2 CRISPR Therapeutics AG 5.39 Bn 5.39 Bn - -
3 Iovance Biotherapeutics 3.98 Bn 3.68 Bn 55.72 Mn -
4 Legend Biotech 3.97 Bn 3.00 Bn 251.50 Mn -
5 uniQure 3.09 Bn 3.09 Bn 5.49 Mn -
6 Beam Therapeutics 3.06 Bn 3.06 Bn - -
7 Precigen 2.54 Bn 2.54 Bn 52.17 Mn -
8 Sarepta Therapeutics 2.38 Bn 1.58 Bn 251.87 Mn -
9 Vericel 2.06 Bn 1.89 Bn 56.40 Mn -
10 BioCardia 13.06 Mn 8.94 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 104,000.00
Sep 30, 2012 532,000.00
Dec 31, 2011 4,000.00
Sep 30, 2011 -404,000.00
Jun 30, 2011 12.25 Mn
Mar 31, 2011 -196,000.00
Dec 31, 2010 -330,000.00
Sep 30, 2010 -8.01 Mn